Announcement
28 Jun 2019
In June 2019, the European Investment Bank (EIB) signed a loan agreement with ISA Pharmaceuticals BV to support the company's development of therapeutic synthetic long peptide vaccine targeting HPV16.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
28 Jun 2019
Revocation date:
No revocation date
Updated: 28 Jun 2019
State loan
In force
On 28 June 2019, the European Investment Bank (EIB) and Dutch ISA Pharmaceuticals BV signed a loan agreement having a total value of EUR 20 million (approx. USD 22.8 million). The&nb...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.